Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IDELALISIB vs IMETELSTAT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IDELALISIB vs IMETELSTAT: Safety Overview

Metric IDELALISIB IMETELSTAT
Total FAERS Reports 6,862 137
Deaths Reported 1,548 18
Death Rate 22.6% 13.1%
Hospitalizations 2,962 37
Average Patient Age 70.0 yrs 77.0 yrs
% Female Patients 38.4% 43.3%
FDA Approval Date Jul 23, 2014 Jun 6, 2024
Manufacturer Gilead Sciences, Inc. Geron Corporation
Route ORAL INTRAVENOUS
Marketing Status Prescription Prescription